Novo Nordisk’s outgoing CEO, Lars Fruergaard Jorgensen, has warned that layoffs at the Danish pharmaceutical giant could be unavoidable as competition heats up against its blockbuster obesity drug ...

As of May 22, manufacturers are no longer allowed to distribute the compounded versions of semaglutide, which Novo Nordisk sells under the brand Wegovy for weight loss and Ozempic for diabetes.

Novo Nordisk, the maker of Wegovy, announced exclusively on "Good Morning America" Tuesday that the medication will soon be available for purchase through the telehealth companies Ro, Hims and ...

Wegovy (semaglutide) is an FDA-approved medication for chronic weight management. Learn more about Wegovy, including how it works and potential risks.

New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how safe the ...

Patients taking the GLP-1 weight loss drug Zepbound face mandatory switch to Wegovy after CVS Caremark removed the Eli Lilly medication from its preferred coverage list, citing rising costs.

Wegovy is a prescription drug used for long-term weight management. Learn about the side effects it can cause and how to manage them.

Novo Nordisk has launched its wildly popular weight-loss drug Wegovy in more than 15 countries since 2021 at prices ranging from $200 to almost $2,000 a month, as Eli Lilly also began selling its ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference? Caroline Thomason, RD, CDCES Sun, December 29, 2024 at 1:42 PM UTC 4 min read ...